Blackburn EH (2001) Switching and signaling at the telomere. Cell 106(6):661–673. https://doi.org/10.1016/s0092-8674(01)00492-5

Article  CAS  PubMed  Google Scholar 

Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J (2007) Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318(5851):798–801. https://doi.org/10.1126/science.1147182

Article  CAS  PubMed  Google Scholar 

Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42:301–334. https://doi.org/10.1146/annurev.genet.41.110306.130350

Article  CAS  PubMed  Google Scholar 

Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345(6274):458–460. https://doi.org/10.1038/345458a0

Article  CAS  PubMed  Google Scholar 

Crompton NE (1997) Telomeres, senescence and cellular radiation response. Cell Mol Life Sci 53(7):568–575. https://doi.org/10.1007/s000180050073

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karlseder J, Smogorzewska A, de Lange T (2002) Senescence induced by altered telomere state, not telomere loss. Science 295(5564):2446–2449. https://doi.org/10.1126/science.1069523

Article  CAS  PubMed  Google Scholar 

de Lange T (2009) How telomeres solve the end-protection problem. Science 326(5955):948–952. https://doi.org/10.1126/science.1170633

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacobs JJ, de Lange T (2004) Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr Biol 14(24):2302–2308. https://doi.org/10.1016/j.cub.2004.12.025

Article  CAS  PubMed  Google Scholar 

Zhang Y, Sturgis EM, Huang Z, Zafereo ME, Wei Q, Li G (2012) Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck. Cancer 118(2):485–492. https://doi.org/10.1002/cncr.26222

Article  CAS  PubMed  Google Scholar 

Uziel O, Yosef N, Sharan R, Ruppin E, Kupiec M, Kushnir M, Beery E, Cohen-Diker T, Nordenberg J, Lahav M (2015) The effects of telomere shortening on cancer cells: a network model of proteomic and microRNA analysis. Genomics 105(1):5–16. https://doi.org/10.1016/j.ygeno.2014.10.013

Article  CAS  PubMed  Google Scholar 

Hiyama E, Hiyama K (2007) Telomere and telomerase in stem cells. Br J Cancer 96(7):1020–1024. https://doi.org/10.1038/sj.bjc.6603671

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen CH, Chen RJ (2011) Prevalence of telomerase activity in human cancer. J Formos Med Assoc 110(5):275–289. https://doi.org/10.1016/S0929-6646(11)60043-0

Article  CAS  PubMed  Google Scholar 

Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193):2011–2015. https://doi.org/10.1126/science.7605428

Article  CAS  PubMed  Google Scholar 

Jafri MA, Ansari SA, Alqahtani MH, Shay JW (2016) Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med 8(1):69. https://doi.org/10.1186/s13073-016-0324-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leão R, Apolónio JD, Lee D, Figueiredo A, Tabori U, Castelo-Branco P (2018) Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer. J Biomed Sci 25(1):22. https://doi.org/10.1186/s12929-018-0422-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan X, Larsson C, Xu D (2019) Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players. Oncogene 38(34):6172–6183. https://doi.org/10.1038/s41388-019-0872-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roake CM, Artandi SE (2020) Regulation of human telomerase in homeostasis and disease. Nat Rev Mol Cell Biol 21(7):384–397. https://doi.org/10.1038/s41580-020-0234-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

MacKenzie D Jr, Watters AK, To JT, Young MW, Muratori J, Wilkoff MH, Abraham RG, Plummer MM, Zhang D (2021) ALT Positivity in Human Cancers: Prevalence and Clinical Insights. Cancers 13(10):2384. https://doi.org/10.3390/cancers13102384

Article  PubMed  PubMed Central  Google Scholar 

Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297. https://doi.org/10.1016/s0092-8674(04)00045-5

Article  CAS  PubMed  Google Scholar 

Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004. https://doi.org/10.1038/sigtrans.2015.4

Article  PubMed  PubMed Central  Google Scholar 

Vannini I, Fanini F, Fabbri M (2018) Emerging roles of microRNAs in cancer. Curr Opin Genet Dev 48:128–133. https://doi.org/10.1016/j.gde.2018.01.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ (2020) Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci 21(5):1723. https://doi.org/10.3390/ijms21051723

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dragomir MP, Knutsen E, Calin GA (2022) Classical and noncanonical functions of miRNAs in cancers. Trends Genet 38(4):379–394. https://doi.org/10.1016/j.tig.2021.10.002

Article  CAS  PubMed  Google Scholar 

Slattery ML, Herrick JS, Pellatt AJ, Wolff RK, Mullany LE (2016) Telomere Length, TERT, and miRNA Expression. PLoS ONE 11(9):e0162077. https://doi.org/10.1371/journal.pone.0162077

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossi M, Gorospe M (2020) Noncoding RNAs controlling telomere homeostasis in senescence and aging. Trends Mol Med 26(4):422–433. https://doi.org/10.1016/j.molmed.2020.01.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central